Swati Biswas

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. pmc Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone
    Swati Biswas
    Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
    PLoS ONE 6:e27090. 2011
  2. pmc Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis
    Vidya Ganapathy
    Division of Medical Oncology, Department of Internal Medicine, UMDNJRobert Wood Johnson Medical School and The Cancer Institute of New Jersey, New Brunswick, NJ, USA
    Mol Cancer 9:122. 2010
  3. pmc Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
    Tapasi Rana
    Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
    PLoS ONE 8:e78043. 2013

Collaborators

  • Yu Shyr
  • Jeffry S Nyman
  • Tapasi Rana
  • Vidya Ganapathy
  • Anwesa Chakrabarti
  • Michael Freeman
  • Alison Grazioli
  • John McPherson
  • Yibin Kang
  • Scott Lonning
  • Whitney Banach-Petrosky
  • Rongrong Ge
  • Gregory R Mundy
  • Wen Xie
  • Michael Reiss
  • Jonathan M Yingling

Detail Information

Publications3

  1. pmc Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone
    Swati Biswas
    Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
    PLoS ONE 6:e27090. 2011
    ..This approach of intervention has the potential to reduce skeletal related events (SREs) in breast cancer survivors...
  2. pmc Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis
    Vidya Ganapathy
    Division of Medical Oncology, Department of Internal Medicine, UMDNJRobert Wood Johnson Medical School and The Cancer Institute of New Jersey, New Brunswick, NJ, USA
    Mol Cancer 9:122. 2010
    ....
  3. pmc Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
    Tapasi Rana
    Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
    PLoS ONE 8:e78043. 2013
    ..In conclusion, a combination therapy using doxorubicin and anti-TGFβ antibody might be beneficial for preventing therapy-related bone loss in cancer patients. ..